• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

experimental study to enhance peripheral nerve regeneration by inhibiting the Schwann cell apoptosis using antisense

Research Project

Project/Area Number 13470308
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionMie University

Principal Investigator

KASAI Yuichi  Mie University, Hospital Research Associate, 医学部附属病院, 助手 (20242943)

Co-Investigator(Kenkyū-buntansha) HIRATA Hitoshi  Mie University, Hospital Assistant Professor, 医学部附属病院, 講師 (80173243)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥11,100,000 (Direct Cost: ¥11,100,000)
Fiscal Year 2002: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2001: ¥9,400,000 (Direct Cost: ¥9,400,000)
KeywordsSchwann Cell / Apoptosis / Nerve regeneratin / antisense / Nerve growth factor receptor / ワーラー変性 / NGF / NGFレセプター
Research Abstract

We have identified p75NTR receptor as a regulator of phenotypic change of Schwann cells during wallerian degeneration and Schwann cell apoptosis in Schwann cell column atrophy. In this project, we tried to develop antisense therapy targeting the receptor to enhance both formation and maintainance of the Schwann cell column, structurally and functionally. We used two classes of antisense : phosphorothioate antisense and morpholino antisense. The inhibition of the receptor on the axons did not show any biological effect on the neuron. In contrast, it affected drastically on Schwann cell biology. Since phosphorothioate antisense induced rapid Schwann cell death due to its non-antisense cytotoxic effect even at 1ug/ml, the lowest concentration required to exert antisense effect. By contrast, morpholino antisense not only significantly enhanced Schwann cell survival but also promoted Schwann cell proliferation without any appreciable side effects. So, moripholino antisense can be a promising candidate for antisense therapy to enhance peripheral nerve regeneration. Due to the lack of effective in vivo delivery system for the antisense, our strategy at present is ex-vivo delivery to the cultured Schwann cell impregnated artifitial nerve constructed by elastin and collagen I.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] S Maniwa, H Hirata, et al.: "EFFECTS OF NEUROTROPHIC FACTORS ON CHEMOKINESIS OF SCHWANN CELLS IN CULTURE"Scand J Plast Reconstr Surg Hang Surg. 37. 14-17 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] "EEFECTS OF NEUROTROPHIC FACTORS ON CHEMOKINESIS OF SCHWANN CELLS IN CULTURE"Scand J Plast Reconstr Surg Hand Surg. 37. 14-17 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] S Maniwa, H Hirata, et al.: "EFFECTS OF NEUROTROPHIC FACTORS ON CHEMOKINESIS OF SCHWANN CELLS IN CULTURE"Scand J Plast Reconstr Surg Hand Surg. 37. 14-17 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hitoshi Hirata, et al.: "Nerve Growth factor signaling of p75 induces differentiation and ceramide-mediated apoptosis in Schwann cells cultured from degenerating nerves"GLIA. 36(3). 245-258 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 明田浩司: "p75NTRに対するアンチセンスを用いたシュワン細胞のアポトーシス抑制"日本整形外科学会雑誌. 75(8). s1062 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi